Antibody targeting of claudin-1 as a potential colorectal cancer therapy

Abstract Background Metastatic colorectal cancer (mCRC) is one of the major causes of cancer-related death. Despite the substantial progress in mCRC management, it remains important to identify new therapeutic options and biological markers for personalized medicine. Here, we investigated the expres...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: S. Cherradi, A. Ayrolles-Torro, N. Vezzo-Vié, N. Gueguinou, V. Denis, E. Combes, F. Boissière, M. Busson, L. Canterel-Thouennon, C. Mollevi, M. Pugnière, F. Bibeau, M. Ychou, P. Martineau, C. Gongora, M. Del Rio
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMC 2017-06-01
Reeks:Journal of Experimental & Clinical Cancer Research
Onderwerpen:
Metastatic
Colorectal cancer
Claudin-1
Antibody
Targeted therapy
Online toegang:http://link.springer.com/article/10.1186/s13046-017-0558-5
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items